FDA Investigator Jennifer L Jager

Jennifer L Jager has inspections in 2 countries as of 24 Oct 2023. Jennifer L Jager has collaborated with a combinined 2577 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
132
Last Inspection Date:
24 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100005490
Country:
United States of America, Germany
Co-Investigator(s):
Alan Escalona, Alec M O'neal, Alexander M Kay, Allison C Hunter, Allison E Sincek, Allison M Scheck, Amy A Johnson, Ana Djurdjevic, Andrew I Carr, Andrew M Kupper, Andrew T Todd, Andria L Kuhlman, Anna M Brannen, Arie R Dyk, Bailey A Uetrecht, Benjamin D Shuler, Blyss L Ketterer, Brandon L Mariner, Brenda C Hamilton, Brigitte K Hofmann, Bryan J Love, Bryce A May, Carlos Hruiz Nunez, Cassandra L Winters, Catherine D Djordjevic, Ching Jeyg Chang, Christian L Witkovskie, Christina L Bigham, Christine E Kelley, Christopher T Middendorf, Craig P Seaborn, Craig T Rybus, Cynthia A Harris, MD, RN, Cynthia L Rakestraw, Cynthia T Cain, D'arbra R Blankenship, Darren S Morgan, David P Moorhead, Dell S Moller, Diane R Mcdaniel, Donna F Campbell, Dorathy M Eischen, Doretha M Tonkins, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Elizabeth Ll Edwards, Elizabeth P Kinsella, Emma A Nesbit, Garrad R Poole, Genevieve E Ghand, Geoffrey K Kilili, Gerald Mierle, Gordon R Davidson, Green, Holly J Rapier, Holly J Wilson, Hugh M Mcclure, II, James G Marsh, James Murphey, Jason D Werne, Jason G Marsh, Jennifer L Gustavus, Jennifer L Sheehan, Jessica M Wooten, John D Jaworski, John E Russell, Jonathan A Ferguson, Joseph X Kaufman, Joshua C Schafer, Joshua S Hunt, Karen M Cooper, Karen M Kondas, Kathleen D Culver, Kathryn J Mccarty, Kathryn Suttling, Keith J Mason, Kelli Wilkinson, Kelly D Moore, Kenneth L Smalls, Kimberly A Joseph, Kirk A Dymbrowski, Klein, Laine P Myers, Laressa R Gray, Laureen M Geniusz, Lauren N Smith, LCDR Wilfred A Darang, Leena Thomas, Leslie R Clark, Linda S Mattingly, Lindsey M Schwierjohann, Logan T Williams, Luckner Jean Marie, Malik S Qaiser, Maney P Sturgill, Marcia A Worley, Marianne Allen, Maribeth G Niesen, Marion W Nadeau, Mark E Parmon, Mary B Sheets, Mary T Carden, Matt D Suedkamp, Matthew B Casale, Meredith M Cobb, Michael D Thatcher, Michael E Campbell, Michael E Clark, Michael I Gorman, Michael J Schibi, Michael K Larson, Michael P Sheehan, Nadeem I Chaudhry, Nancy L Neiger, Nicholas L Paulin, Nisha C Patel, Phillip M Pontikos, Pifer, Richard J Bashay, Richard W Berning, Robert Rodriguez, Rosanna M Goodrich, Roy C Stephens, Said H Muse, Samuel A Hamblin, Sean R Moynihan, MPH, Shannon A Gregory, Sherry L Secrist, BLT DO, State Agency, Stephen J Rabe, Steven P Eastham, Susan M Taylor, Tamara M Kays, Teresa K Kastner, Thomas B Smith, Thomas C Woods, Thomas J Prigge, Thomas W Nojek, Thunder N Dunkijacobs, Tracey L Harris, Travis R Hunt, Troy A Huffman, Wen Ning Chan (Sally), Yvette Mlacour Davis

Jennifer L Jager's Documents

Publish Date Document Type Title
February, 2011 FDA 483 Miami Valley Hospital-Irb - Form 483, 2011-02-18
March, 2011 FDA 483 Anthony Grote - Form 483, 2011-03-30
April, 2013 EIR David J. Portman M.D. - EIR, 2012-10-26
January, 2013 EIR Nationwide Children's Hospital IRB - EIR, 2013-01-25
April, 2013 FDA 483 David J. Portman M.D. - Form 483, 2012-10-26
March, 2012 FDA 483 Wright State University IRB - Form 483, 2012-03-15
January, 2013 FDA 483 Hoxworth Blood Center University of Cincinnati - Form 483, 2013-01-07
June, 2011 FDA 483 Joe Siefring - Form 483, 2011-06-30
February, 2014 EIR Michael J Noss MD - EIR, 2014-02-20
January, 2013 EIR Hoxworth Blood Center University of Cincinnati - EIR, 2013-01-07
January, 2013 FDA 483 Nationwide Children's Hospital IRB - Form 483, 2013-01-25
April, 2013 EIR David J. Portman M.D. - EIR, 2013-04-11
October, 2014 FDA 483 Manisha H Shah, M.D. - Form 483, 2014-10-17
June, 2014 EIR LifeNet Health - EIR, 2014-06-09
October, 2014 EIR Manisha H Shah, M.D. - EIR, 2014-10-17

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more